Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
European Journal of Gastroenterology & Hepatology
|
November 1, 2000
The safe use of percutaneous gastrostomy for enteral nutrition in patients with Crohn's disease
Q M Anstee, A Forbes
Journal of Hepatology
|
October 22, 2011
A lipid to treat non-alcoholic fatty liver disease - the dawn of 'lipo-rehabilitation'?
Q M Anstee, C P Day
Alimentary Pharmacology & Therapeutics
|
April 11, 2016
Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis
M Noureddin, Q M Anstee, R Loomba
Frontline Gastroenterology
|
October 7, 2014
Non-alcoholic fatty liver disease: a practical approach to treatment
J K Dyson, Q M Anstee, S McPherson
Journal of Clinical Pathology
|
August 14, 2013
Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification
J K Dyson, S McPherson, Q M Anstee
Postgraduate Medical Journal
|
April 17, 2014
Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification
J K Dyson, S McPherson, Q M Anstee
Postgraduate Medical Journal
|
February 7, 2015
Republished: Non-alcoholic fatty liver disease: a practical approach to treatment
J K Dyson, Q M Anstee, S McPherson
HIV Medicine
|
August 31, 2018
Central obesity and nonalcoholic fatty liver disease in people living with HIV: a case for targeted screening?
C Dewar, Q M Anstee, D A Price, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 7, 2011
Hypercoagulability in cirrhosis: causes and consequences
A Tripodi, Q M Anstee, K K Sogaard, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 20, 2008
Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies
Q M Anstee, R D Goldin, M Wright, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
European Journal of Gastroenterology & Hepatology
|
November 1, 2000
The safe use of percutaneous gastrostomy for enteral nutrition in patients with Crohn's disease
Q M Anstee, A Forbes
Journal of Hepatology
|
October 22, 2011
A lipid to treat non-alcoholic fatty liver disease - the dawn of 'lipo-rehabilitation'?
Q M Anstee, C P Day
Alimentary Pharmacology & Therapeutics
|
April 11, 2016
Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis
M Noureddin, Q M Anstee, R Loomba
Frontline Gastroenterology
|
October 7, 2014
Non-alcoholic fatty liver disease: a practical approach to treatment
J K Dyson, Q M Anstee, S McPherson
Journal of Clinical Pathology
|
August 14, 2013
Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification
J K Dyson, S McPherson, Q M Anstee
Postgraduate Medical Journal
|
April 17, 2014
Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification
J K Dyson, S McPherson, Q M Anstee
Postgraduate Medical Journal
|
February 7, 2015
Republished: Non-alcoholic fatty liver disease: a practical approach to treatment
J K Dyson, Q M Anstee, S McPherson
HIV Medicine
|
August 31, 2018
Central obesity and nonalcoholic fatty liver disease in people living with HIV: a case for targeted screening?
C Dewar, Q M Anstee, D A Price, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 7, 2011
Hypercoagulability in cirrhosis: causes and consequences
A Tripodi, Q M Anstee, K K Sogaard, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 20, 2008
Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies
Q M Anstee, R D Goldin, M Wright, et al.
Page
of 2